China Universal Asset Management Co., Ltd. Nurix Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,020 shares of NRIX stock, worth $299,348. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,020
Previous 12,388
21.25%
Holding current value
$299,348
Previous $278,000
1.44%
% of portfolio
0.03%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding NRIX
# of Institutions
180Shares Held
68.1MCall Options Held
78KPut Options Held
53.8K-
Black Rock Inc. New York, NY6.82MShares$136 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.28MShares$85.3 Million6.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$80 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$77.4 Million0.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.87MShares$77.1 Million3.2% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $940M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...